4.6 Article

Transcriptional and Post-Transcriptional Down-Regulation of Cyclin D1 Contributes to C6 Glioma Cell Differentiation Induced by Forskolin

期刊

JOURNAL OF CELLULAR BIOCHEMISTRY
卷 112, 期 9, 页码 2241-2249

出版社

WILEY
DOI: 10.1002/jcb.23140

关键词

CYCLIN D1; GSK-3 beta; GLIOMA; FORSKOLIN; DIFFERENTIATION; CELL CYCLE

资金

  1. National Natural Science Foundation of China [30830111, 30801408]
  2. National Natural Science Foundation of Guangdong Province [8451008901000297]
  3. Chinese Postdoctoral Science [20100480824]
  4. Guangzhou Scientific and Technological Programs [2008Z1-E561]

向作者/读者索取更多资源

Malignant gliomas are the most common and lethal intracranial tumors, and differentiation therapy shows great potential to be a promising candidate for their treatment. Here, we have elaborated that a PKA activator, forskolin, represses cell growth via cell cycle arrest in the G0/G1 phase and induces cell differentiation characteristic with elongated processes and restoration of GFAP expression. In mechanisms, we verified that forskolin significantly diminishes the mRNA and protein level of a key cell cycle regulator cyclin D1, and maintenance of low cyclin D1 expression level was required for forskolin-induced proliferation inhibition and differentiation by gain and loss of function approaches. In addition, that forskolin down-regulated the cyclin D1 by proteolytic (post-transcriptional) mechanisms was dependent on GSK-3 beta activation at Ser9. The pro-differentiation activity of forskolin and related molecular mechanisms imply that forskolin can be developed into a candidate for the future in differentiation therapy of glioma, and cyclin D1 is a promising target for pro-differentiation strategy. J. Cell. Biochem. 112: 2241-2249, 2011. (C) 2011 Wiley-Liss, Inc.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据